| Literature DB >> 32236871 |
Abstract
Conventional treatment of X-linked hypophosphataemia (XLH) consists in the oral administration of phosphate plus calcitriol supplements. Although this therapy has reduced bone deformities and even achieved adequate patient growth, overtreatment or low adherence could lead to subsequent consequences that may compromise the efficacy of the therapy. Some of the complications associated with phosphate and vitamin D treatment are abdominal discomfort, diarrhoea, hypokalaemia, hyperparathyroidism, hypercalcaemia or hypercalciuria, nephrocalcinosis or nephrolithiasis, and ectopic calcifications. Therefore, constant multidisciplinary monitoring of patients with XLH is necessary to prevent the manifestation of these complications and to deal with them as soon as they appear. The main objective of this article is to review the main complications arising from conventional treatment of XLH and how to deal with them.Entities:
Keywords: FGF23; Growth hormone; Hypercalcaemia; Hyperparathyroidism; Nephrocalcinosis
Mesh:
Substances:
Year: 2020 PMID: 32236871 DOI: 10.1007/s12325-019-01170-7
Source DB: PubMed Journal: Adv Ther ISSN: 0741-238X Impact factor: 3.845